Cover Image

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies

Saved in:

Bibliographic Details
Main Authors:	Fanfan Zhou (Author), Hong Zhu (Author), Caiyun Fu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
by: Zhuo Shao, et al.
Published: (2021)

Editorial: Novel therapeutic approaches to target drug resistant tumors
by: Chiara Riganti, et al.
Published: (2023)

Editorial: Therapeutic targeting of splicing variants in cancer
by: Pouya Sarvari, et al.
Published: (2023)

Editorial: Epigenetic regulation and therapy resistance in cancer
by: Yongxia Zhu, et al.
Published: (2023)

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
by: Marie Angèle Cucci, et al.
Published: (2023)

TNFAIP2 as an emerging therapeutic target in cancer therapy and its underlying mechanisms
by: Zhanqi Fu, et al.
Published: (2024)

TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
by: Yixuan Liu, et al.
Published: (2021)

Targeted Cancer Therapy and Mechanisms of Resistance
Published: (2022)

Editorial: Peptidases as a therapeutic target in anti-cancer management
by: Ana Mitrović, et al.
Published: (2024)

A pan-cancer study of selenoprotein genes as promising targets for cancer therapy
by: Wentao Wu, et al.
Published: (2021)

Editorial: The developments of metal-based agents against lung cancer
by: Yi Gou, et al.
Published: (2022)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
by: Jian Chen, et al.
Published: (2022)

Editorial: Sepsis: Basic, Clinical and Therapeutic Approaches
by: Yan Kang, et al.
Published: (2022)

Editorial: Chemo-Radiation-Resistance in Cancer Therapy
by: Xiaoping Lin, et al.
Published: (2022)

Editorial: Adaptive immune resistance in cancer therapy
by: Aimin Jiang, et al.
Published: (2023)

Editorial: Matricellular receptors as potential targets in anti-cancer therapeutic strategies
by: Hervé eEmonard, et al.
Published: (2016)

Editorial: Novel small molecules in targeted cancer therapy
by: Rong Li, et al.
Published: (2023)

MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters
by: Xin-Yan Lu, et al.
Published: (2024)

Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
by: Shih-Cheng Pao, et al.
Published: (2022)

RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer
by: Sakib Haque, et al.
Published: (2021)

Editorial: New strategies for reversing cancer therapy resistance
by: Yue Du, et al.
Published: (2024)

Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer
by: Tasia Bos, et al.
Published: (2021)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
by: Alena Mazurakova, et al.
Published: (2023)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
by: Zhi Shi, et al.
Published: (2022)

Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy
by: Dong-Hee Lee, et al.
Published: (2021)

Clinical Advancements in the Targeted Therapies against Liver Fibrosis
by: Ruchi Bansal, et al.
Published: (2016)

Editorial: Sepsis: basic, clinical and therapeutic approaches, volume II
by: Hong Zhou, et al.
Published: (2023)

N-Methyl-D-Aspartate (NMDA) Receptors: Therapeutic Target against Cancer
by: Raj Kumar Koiri, et al.
Published: (2015)

Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
by: Srinivas Patnaik, et al.
Published: (2019)

Editorial: Immunity in the development of anti-cancer drug resistance
by: Ya Meng, et al.
Published: (2022)

Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
by: Xuan Liu, et al.
Published: (2022)

Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy
by: Xing Wang, et al.
Published: (2021)

Editorial: Targeting ion homeostasis for cancer therapy: mechanisms and immunomodulatory effects
by: Xuemei Zeng, et al.
Published: (2024)

Potential Therapeutic Targets for Combination Antibody Therapy against <i>Pseudomonas aeruginosa</i> Infections
by: Luke L. Proctor, et al.
Published: (2021)

Potential Therapeutic Targets for Combination Antibody Therapy Against <i>Staphylococcus aureus</i> Infections
by: Sharon Ke, et al.
Published: (2024)

Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC
by: Chenxin Li, et al.
Published: (2022)

Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
by: Linsheng Liu
Published: (2022)

Targeting calcium signaling in cancer therapy
by: Chaochu Cui, et al.
Published: (2017)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
by: Chrishan S. Samuel, et al.
Published: (2017)

Editorial: IBD Management-Novel Targets and Therapeutic Perspectives
by: Luca Antonioli, et al.
Published: (2020)